RxDoctor Payments Data

Michael Galloway, MD

Radiation Oncology · Elkins, WVNPI 1780654913

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $648, 3.4 times the $189 reported in 2019.

$1,462in general payments, 2019–2025

Across 62 payments — averaging $23.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$211
  • Novartis$197
  • AstraZeneca$136
  • Geron Corporation$122
  • Bayer$117
  • Johnson & Johnson$104
  • plus $574 from 16 others

What the payments were for

  • Food & beverage$1,44899%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,462 in reported general payments places this provider in the 80th percentile of 29 radiation oncology providers in West Virginia.

See all radiation oncology providers in West Virginia

Medicare billing

Part B allowed, 2024
$56,417
Medicare patients
70
Services billed
578

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Elkins

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →